Hibernating myocardium has reduced blood flow at rest that increases with low-dose dobutamine

Area of Science:

• Cardiology
• Nuclear Cardiology
• Cardiovascular Imaging

Background:

• Dobutamine stress testing is used to assess coronary artery disease (CAD) and myocardial viability.
• Previous studies have shown dobutamine can improve left ventricular (LV) wall motion in patients with abnormal function.
• The relationship between myocardial blood flow (MBF) and LV dysfunction in CAD requires further clarification.

Discussion:

• Sun and coworkers' study provides crucial data on dobutamine's effects in heart muscle (HM) conditions.
• The research highlights dobutamine's dual role: improving abnormal LV wall motion while posing a risk of infarction.
• It reinforces the association between perfusion-metabolism mismatch on PET imaging and reduced resting MBF in HM.

Key Insights:

• Dobutamine demonstrates an inotropic effect and an attenuated coronary vasodilator reserve in HM.
• Improvement in abnormal LV wall motion with dobutamine is a real phenomenon in many patients.
• Areas of perfusion-metabolism mismatch in HM correlate with reduced MBF at rest.

Outlook:

• Further investigation is needed to understand the potential deleterious effects of dobutamine, such as infarction, in HM.
• Caution is advised when using dobutamine in HM patients due to potential risks.
• The study's findings on LV dysfunction with normal MBF in CAD warrant careful consideration and potentially further validation.